NHS National Services Scotland Information Services Division. Cancer incidence in Scotland (2016). 2016. (accessed 1 May 2020)

Prostate Cancer Results Study Group. Brachytherapy: most effective treatment for prostate cancer. 2016. (accessed 1 May 2020)

Prostate Scotland. What is prostate cancer?. 2020. (accessed 1 May 2020)

Scottish Public Health Observatory. Prostate cancer: Scottish data. 2019. (accessed 1 May 2020)

Shrestha A, Martin C, Burton M, Walters S, Collins K, Wyld L. Quality of life versus length of life considerations in cancer patients: a systematic literature review. Psychooncology. 2019; 28:(7)1367-1380 10.1002/pon.5054

Prostate cancer in Scotland: an evolutionary journey

28 May 2020
Volume 29 · Issue 10

Prostate cancer remains the most common male cancer in Scotland, accounting for more than 20% of all cancers diagnosed in men (Scottish Public Health Observatory, 2019). It is the largest cause of male cancer deaths. Although the number of cases per year has largely stayed the same in the past decade (NHS National Services Scotland Information Services Division, 2016), survival rates are improving, particularly where diagnosis is early (Prostate Scotland, 2020). The development of new technologies and treatments has undoubtedly contributed to improvements in outcomes. Alongside this, the ability to redesign pathways in line with technological advances, patients' needs and consumer expectations has become another critical success factor. This has certainly been the case at Edinburgh Cancer Centre, where prostate cancer pathways have evolved considerably since our brachytherapy service was first introduced in 2001.

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content